Biosynthesis of Phosphorylcholine Oligosaccharides
磷酰胆碱寡糖的生物合成
基本信息
- 批准号:7126266
- 负责人:
- 金额:$ 20.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-01 至 2008-08-31
- 项目状态:已结题
- 来源:
- 关键词:Caenorhabditis elegansMycobacteriumRNA interferenceSaccharomyces cerevisiaecomplementary DNAenzyme activitygreen fluorescent proteinshelminth geneticsinhibitor /antagonistmutantoligosaccharidesphosphorylcholineprotein localizationprotein purificationprotein structure functionproteomicssphingomyelin phosphodiesterasetransfection /expression vector
项目摘要
DESCRIPTION (provided by applicant): Filarial nematodes infect approximately 150 million people and animals by modulating or suppressing the immune system of the host. Previous studies have suggested that the anti-inflammatory action of phosphorylcholine oligosaccharide -containing proteins, occurring in nematodes, but not in the hosts, play an important role in this process. The specific aim of this R21, high risk/high impact, grant proposal is to clone the phosphorylcholine oligosaccharide synthase(s) of C. elegans, a nematode whose complete genome sequence is known and because of its ease of manipulation and lack of pathogenicity should be an attractive model to study the biosynthesis of such molecules in filarial nematodes. For the above goal we propose to pursue two complementary approaches. Based on the putative mechanistic similarities between the recently cloned sphingomyelin synthases and phosphorylcholine oligosaccharide synthases, we will express C. elegans cDNAs, encoding either known or related genes of sphingomyelin synthases in S. cerevisiae. Extracts from the transformed yeast, which don't have endogenous sphingomyelin synthases, will be assayed for synthesis of phosphorylcholine oligosaccharides. We hypothesize that sphingomyelin synthases of nematodes may have both enzymatic activities or that the related genes may have phosphorylcholine oligosaccharide synthase activity. Should the above approach not succeed then a highly purified fraction containing synthase activity from C. elegans will be obtained and subjected to proteomic analysis and examination on the basis of the complete genome of C. elegans. Candidate genes will be expressed in S. cerevisiae and assayed for phosphorylcholine oligosaccharide synthase activity. These studies, if successful, will constitute the basis for (a) attempts to clone the phosphorylcholine oligosaccharide synthase from filarial nematodes including Brugia malayi, Brugia pahangi and Achanthocheilonema vitae and (b) biochemical characterization of the synthase from C. elegans including identification of possible inhibitors. The absence of this reaction in hosts makes identification of potential inhibitors attractive therapeutic targets.
描述(由申请人提供):丝虫线虫通过调节或抑制宿主的免疫系统感染大约 1.5 亿人和动物。先前的研究表明,在线虫中而非宿主中存在的含磷酸胆碱寡糖的蛋白质的抗炎作用在此过程中发挥重要作用。该 R21 高风险/高影响拨款提案的具体目标是克隆秀丽隐杆线虫的磷酸胆碱寡糖合酶,线虫是一种线虫,其完整基因组序列已知,并且由于其易于操作且缺乏致病性,应该成为研究丝虫线虫中此类分子生物合成的一个有吸引力的模型。为了实现上述目标,我们建议采取两种互补的方法。基于最近克隆的鞘磷脂合酶和磷酸胆碱寡糖合酶之间假定的机制相似性,我们将表达秀丽隐杆线虫cDNA,编码酿酒酵母中鞘磷脂合酶的已知或相关基因。转化酵母的提取物不具有内源性鞘磷脂合酶,将用于分析磷酸胆碱寡糖的合成。我们推测线虫的鞘磷脂合酶可能同时具有这两种酶活性,或者相关基因可能具有磷酸胆碱寡糖合酶活性。如果上述方法不成功,则将获得来自秀丽隐杆线虫的含有合酶活性的高度纯化的级分,并基于秀丽隐杆线虫的完整基因组进行蛋白质组分析和检查。候选基因将在酿酒酵母中表达并测定磷酸胆碱寡糖合酶活性。这些研究如果成功,将构成以下基础:(a) 尝试从丝虫线虫(包括马来丝虫、彭亨丝虫和 Achanthocheilonema vitae)克隆磷酸胆碱寡糖合酶;以及 (b) 线虫合酶的生化表征,包括鉴定可能的抑制剂。宿主体内不存在这种反应使得潜在抑制剂的鉴定成为有吸引力的治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARLOS Benjamin HIRSCHBERG其他文献
CARLOS Benjamin HIRSCHBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARLOS Benjamin HIRSCHBERG', 18)}}的其他基金
PROTEOMIC ANALYSES OF PERLECAN MRNA-ASSOCIATED PROTEIN COMPLEXES
PERLECAN mRNA 相关蛋白复合物的蛋白质组学分析
- 批准号:
8365859 - 财政年份:2011
- 资助金额:
$ 20.31万 - 项目类别:
Biosynthesis of Phosphorylcholine Oligosaccharides
磷酰胆碱寡糖的生物合成
- 批准号:
7282737 - 财政年份:2006
- 资助金额:
$ 20.31万 - 项目类别:
TOPOGRAPHY OF GLYCOSYLATION IN THE ENDOPLASMIC RETICULUM
内质网糖基化的拓扑结构
- 批准号:
3432429 - 财政年份:1992
- 资助金额:
$ 20.31万 - 项目类别:
TOPOGRAPHY OF GLYCOSYLATION IN THE ENDOPLASMIC RETICULUM
内质网糖基化的拓扑结构
- 批准号:
2291423 - 财政年份:1992
- 资助金额:
$ 20.31万 - 项目类别:
TOPOGRAPHY OF GLYCOSYLATION IN THE ENDOPLASMIC RETICULUM
内质网糖基化的拓扑结构
- 批准号:
2291426 - 财政年份:1992
- 资助金额:
$ 20.31万 - 项目类别:
相似国自然基金
GPNMB通过靶向溶酶体蛋白VAMP8促进麻风分枝杆菌免疫逃逸的机制研究
- 批准号:82304038
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
分枝杆菌诱导宿主SLC7A11介导的肉芽肿新生血管生成进而促进感染的机制研究
- 批准号:82372263
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Rv3737促进M2型巨噬细胞极化在结核分枝杆菌感染中的作用及机制研究
- 批准号:82360002
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
脂肪酸腺苷化酶FadD21在结核分枝杆菌感染与免疫逃逸中的作用及机制研究
- 批准号:82302529
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
工程化CRISPR蛋白增强核酸检测灵敏度及耦合微流控技术实现高通量结核分枝杆菌耐药检测的研究
- 批准号:82300128
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Interplay of M. tuberculosis trehalose metabolism and its pathogenesis and drug resistance
结核分枝杆菌海藻糖代谢及其发病机制和耐药性的相互作用
- 批准号:
10585346 - 财政年份:2023
- 资助金额:
$ 20.31万 - 项目类别:
Mechanisms of macrolide synergy in Mycobacterium tuberculosis
大环内酯类药物在结核分枝杆菌中的协同作用机制
- 批准号:
10386174 - 财政年份:2022
- 资助金额:
$ 20.31万 - 项目类别:
Investigating genetic regulators of Mycobacterium tuberculosis cell division and their role in persistent tuberculosis infection
研究结核分枝杆菌细胞分裂的遗传调节因子及其在持续性结核感染中的作用
- 批准号:
10604773 - 财政年份:2022
- 资助金额:
$ 20.31万 - 项目类别:
Determinants of antigen specific CD4 T cell function in tuberculosis
结核病中抗原特异性 CD4 T 细胞功能的决定因素
- 批准号:
10379400 - 财政年份:2021
- 资助金额:
$ 20.31万 - 项目类别: